Adele Noè

Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual‐Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi)

Jessie Gu, Adele Noè, Priya Chandra et al. · The Journal of Clinical Pharmacology · 2009 · 502 citations

Medicine, Pharmacokinetics, Pharmacology +17

Initiation of Sacubitril/Valsartan in Haemodynamically Stabilised Heart Failure Patients in Hospital or Early After Discharge: Primary Results of the Randomised TRANSITION Study

Rolf Wachter, Michele Senni, Jan Bělohlávek et al. · European Journal of Heart Failure · 2019 · 352 citations · Full text

Medicine, Cardiology, Pharmacology +16

International REgistry to Assess Medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): Rationale for and Design of a Global Registry

Gerasimos Filippatos, Sadiya S. Khan, Andrew P. Ambrosy et al. · European Journal of Heart Failure · 2015 · 67 citations · Full text

Medicine, Cardiology, Internal Medicine +14

Initiation of Sacubitril/Valsartan Shortly After Hospitalisation for Acutely Decompensated Heart Failure in Patients with Newly Diagnosed ( <i>de novo</i> ) Heart Failure: A Subgroup Analysis of the TRANSITION Study

Michele Senni, Rolf Wachter, Klaus K. Witte et al. · European Journal of Heart Failure · 2019 · 64 citations · Full text

Medicine, Cardiology, Pharmacotherapy +11

Rationale and Design of TRANSITION: A Randomized Trial of Pre-Discharge vs. Post-Discharge Initiation of Sacubitril/Valsartan

Domingo A. Pascual‐Figal, Rolf Wachter, Michele Senni et al. · ESC Heart Failure · 2017 · 59 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +14